Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.0702
-0.0080 (-10.23%)
Aug 14, 2025, 11:21 AM - Market open

Adaptimmune Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-169.76-70.81-113.87-165.46-158.09-130.09
Upgrade
Depreciation & Amortization
10.6311.239.846.086.577.59
Upgrade
Asset Writedown & Restructuring Costs
10.410.4----
Upgrade
Loss (Gain) From Sale of Investments
-1.73-1.27-1.992.535.283.84
Upgrade
Stock-Based Compensation
7.8812.0511.7718.2420.6310.41
Upgrade
Other Operating Activities
1.612.18-21.68-1.621.71-1.39
Upgrade
Change in Accounts Receivable
-0.1829.77-1.29-9.81-19.361.75
Upgrade
Change in Inventory
-11.4-7.36----
Upgrade
Change in Accounts Payable
-2.89.62-9.094.414.213.87
Upgrade
Change in Unearned Revenue
-36.36-69.8-14.573.87149.7947.97
Upgrade
Change in Other Net Operating Assets
1.680.79---2.46
Upgrade
Operating Cash Flow
-190.03-73.21-140.88-141.7710.73-53.59
Upgrade
Capital Expenditures
-1.64-0.89-4.68-29.5-8.57-2.34
Upgrade
Cash Acquisitions
--45.26---
Upgrade
Sale (Purchase) of Intangibles
-1.25-1.83-0.2-0.24-0.21-0.57
Upgrade
Investment in Securities
4.5-56.36135.03118.8884.58-276.02
Upgrade
Other Investing Activities
0.180.131.12---
Upgrade
Investing Cash Flow
1.79-58.95176.5489.1475.8-278.92
Upgrade
Long-Term Debt Issued
-49.5----
Upgrade
Net Debt Issued (Repaid)
-0.4549.5----
Upgrade
Issuance of Common Stock
1.7929.250.8812.873.29340.05
Upgrade
Financing Cash Flow
1.3478.750.8812.873.29340.05
Upgrade
Foreign Exchange Rate Adjustments
--0.40.88-2.30.37-0.96
Upgrade
Net Cash Flow
-186.9-53.8137.42-42.0690.186.58
Upgrade
Free Cash Flow
-191.67-74.09-145.56-171.272.16-55.93
Upgrade
Free Cash Flow Margin
-294.49%-41.62%-241.47%-630.86%35.05%-1413.14%
Upgrade
Free Cash Flow Per Share
-0.74-0.29-0.72-1.060.01-0.39
Upgrade
Cash Interest Paid
2.092.09----
Upgrade
Cash Income Tax Paid
1.531.5340.630.540.08
Upgrade
Levered Free Cash Flow
-119.022.17-69.17-111.24-75.01-62.81
Upgrade
Unlevered Free Cash Flow
-115.484.26-69.17-111.24-75.01-62.81
Upgrade
Change in Working Capital
-49.06-36.98-24.95-1.53134.6356.05
Upgrade
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q